Browse the corpus

REFERENCES American Academy of Pediatrics, "ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents," Pediatrics , 2011, 128(5):1007-22. American Academy of Pediatrics/American Heart Association Clarification of Statement on Cardiovascular Evaluation and Monitoring of Children and Adolescents With Heart Disease Receiving Medications for ADHD; available at: file://americanheart.mediaroon.com/index.php?s=43&item=422. Biderman J, Heiligenstein JH, Faries DE, at al, “Efficacy of Atomoxetine Versus Placebo in School-Age Girls With Attention-Deficit/Hyperactivity Disorder,” Pediatrics , 2002, 110(6), file://www.pediatrics.org/cgi/content/full/110/6/e75. Cooper WO, Habel LA, Sox CM, et al, "ADHD Drugs and Serious Cardiovascular Events in Children and Young Adults," N Engl J Med , 2011, 365(20):1896-904. [PubMed 22043968 ] Dopheide JA and Pliszka SR, "Attention-Deficit-Hyperactivity Disorder: An Update," Pharmacotherapy , 2009, 29(6):656-79. [PubMed 19476419 ] Gould MS, Walsh BT, Munfakh JL, et al, "Sudden Death and Use of Stimulant Medications in Youths," Am J Psychiatry , 2009, 166(9):992-1001. [PubMed 19528194 ] Kratochvil CJ, Heiligenstein JH, Dittmann R, et al, “Atomoxetine and Methylphenidate Treatment in Children With ADHD: A Prospective, Randomized, Open-Label trial,” J Am Acad Child Adolesc Psychiatry , 2002, 41(7):776-84. [PubMed 12108801 ] Michelson D, Allen AJ, Busner J, et al, “Once-Daily Atomoxetine Treatment for Children and Adolescents With Attention Deficit Hyperactivity Disorder: A Randomized, Placebo-Controlled Study,” Am J Psychiatry , 2002, 159(11):1896-901. [PubMed 12411225 ] Michelson D, Faries D, Wernicke J, et al, “Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Ramdomized, Placebo-Controlled, Dose-Response Study,” Pediatrics , 2001, 108(5), file://www.pediatrics.org/cgi/content/full/108/5/e83. [PubMed 11694667 ] Newcorn JH, Michelson D, Kratochvil CJ, et al, "Low-Dose Atomoxetine for Maintenance Treatment of Attention-Deficit/Hyperactivity Disorder," Pediatrics , 2006, 118(6):e1701-6. [PubMed 17101710 ]

Michelson D, Faries D, Wernicke J, et al, “Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Ramdomized, Placebo-Controlled, Dose-Response Study,” Pediatrics , 2001, 108(5), file://www.pediatrics.org/cgi/content/full/108/5/e83. [PubMed 11694667 ] Newcorn JH, Michelson D, Kratochvil CJ, et al, "Low-Dose Atomoxetine for Maintenance Treatment of Attention-Deficit/Hyperactivity Disorder," Pediatrics , 2006, 118(6):e1701-6. [PubMed 17101710 ] Pliszka S and AACAP Work Group on Quality Issues, "Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder," J Am Acad Child Adolesc Psychiatry , 2007, 46(7):894-921. [PubMed 17581453 ] Spencer T, Heiligenstein JH, Biederman J, et al, “Results From 2 Proof-of-Concept, Placebo-Controlled Studies of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder,” J Clin Psychiatry , 2002, 63(12):1140-7. [PubMed 12523874 ] Vetter VL, Elia J, Erickson C, et al, "Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing," Circulation , 2008, 117(18):2407-23. [PubMed 18427125 ] Wernicke JF and Kratochvil CJ, “Safety Profile of Atomoxetine in the Treatment of Children and Adolescents With ADHD,” J Clin Psychiatry , 2002, 63(Suppl 12):50-5. [PubMed 12562062 ] Topic 13048 Version 40.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [0604-125.39.66.147-27EA24A548-S244013.14]